Применение бетагистинов в клинической практике. Результаты сравнительного многоцентрового исследования

Ю. Ю. Ковалева, А Б Гехт, А. В. Лебедева et al. · Лечебное дело · 2011

We assessed effectiveness, safety and tolerability of betahistine in neurologic outpatients with dizziness. We examined 200 patients treated with 48 mg/d of betahistine during 60 days. Common state was assessed on visual and analog scale. Severity of dizziness was assessed with questionnaire and DHI (Dizziness Handicap Inventory) scale. In all groups treatment was associated with positive changes in neurologic status: decrease of nistagm, improvement of digitonasal test and Romberg test. We found a significant decrease in dizziness severity and improvement of common state. Treatment with Betaserc resulted in significantly faster appearance of results vs treatment with Vestibo or Betaver.

Cited by 0 works.

Authors